WIRB Copernicus Group (WCG) has expanded its portfolio of companies to include the pharmacovigilance and drug safety solution provider Vigilare International.
Avista Capital Partners has signed an agreement to acquire United BioSource (UBC), adding another pharmaceutical service provider to the firm’s list of current and historical investments.
Clinerion has expanded its patient recruitment system (PRS) platform to provide its clients, pharma companies, and contract research organizations (CROs) greater access to potential clinical trial participants.
Icon plc has launched a new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments as the industry continues to struggle with clinical trial recruitment.
Recipharm says three more of its facilities are equipped and ready for US Drug Supply Chain Security Act (DSCSA) serialisation demands, the deadline for which passes today.
The US FDA has issued Establishment Inspection Reports (EIRs) closing out inspections at Biocon’s biomanufacturing plant in Bangalore and a Divi’s Lab facility in Visakhapatnam.
ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.
AmerisourceBergen Corporation will buy US wholesaler H.D. Smith, which it says will boost capabilities and help secure the pharmaceutical supply chain.
The US Food and Drug Administration has approved ViiV Healthcare’s two-drug treatment for HIV-1 maintenance, the first time the drugs have been combined into a single pill.
A Chinese regulatory institute has opened a non-animal testing laboratory – a model for regulatory bodies to show that implementing alternative methods into government laboratories is achievable, says IIVS president.
ArisGlobal has launched a new platform to report potential adverse events in response to technology trends, which necessitate the immediate availability of information.
Avantor, Inc. has completed its previously announced acquisition of VWR Corporation to create a global provider of “discovery-to-delivery” solutions, says CEO.
Encouraged by a North Carolina state grant, Fresenius Kabi will expand its prefilled syringes business acquired from Becton, Dickinson and Company in 2016.
Quanticate has launched an upgraded statistical monitoring service following the ICH’s good clinical practice (GCP) E6(R2) addendum designed to streamline clinical trials.
The US Food and Drug Administration (FDA) has approved Emergent BioSolutions’ supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, the only FDA-licensed smallpox vaccine, as the company looks to expand its CMO services.
The industry is expected to use an increasing amount of real world evidence, including social media data, which will be used to support new drug applications, according to a recent Tufts report.
Boehringer Ingelheim has launched a new platform through which it will offer open access to selected preclinical molecules in order to 'unlock the full potential' of compounds no longer under development by the company.
European member states have selected Amsterdam as the post-Brexit home of the European Medicines Agency, following a secret ballot vote in Brussels yesterday.
An increasing number of clinical trials and a decreasing amount of unemployment are creating a significant talent demand as the contract research industry continues to experience employee turnover.
Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.
The International Pharmaceutical Excipient Council (IPEC) has updated its Quality Agreement guidelines to reflect changing regulatory expectations and global nature of supply chains.
Scientists have developed opioid pain relievers that do not slow or stop breathing – the cause of opiate overdose – they say could reduce the risk of accidental death.
Corium says it is in talks with commercialisation partners for its transdermal Alzheimer’s disease candisate Corplex Donepezil ahead of a potential 2019 launch.
Acorda Therapeutics has halted enrolment for a trial of its Parkinson’s disease candidate tozadenant after the emergence of serious adverse events, including five deaths.
Pharma firms making product benefit claims on Twitter must incorporate risk information within the same tweet regardless of character space limitations, says the US FDA.
Otsuka Pharmaceutical’s pill embedded with a sensor that digitally verifies if patients have taken their medication has received US approval for mental illness indications.
China is determined to become a bigger player in the pharmaceutical market, and with more opportunities for cross-border collaboration, WuXi AppTec aims to be the world’s largest platform for drug research and development.
Interpol has seized more than 300kg of counterfeit pharmaceutical products in West Africa’s Cote d’Ivoire, and uncovered a packaging site for fake medicines.
Peregrine Pharmaceuticals was a biotech company – now, the company is transitioning to a pure-play contract development and manufacturing organization (CDMO) as it sells off its R&D assets.
Evotec is collaborating with academic institutions to develop a device to test drug candidates in the kidney, which it says could improve and accelerate clinical trials.
Pfizer has sold its share of a joint venture with Zhejiang Hisun Pharmaceuticals but will continue supporting the local production of generic drugs in China.
Quotient Clinical unveiled its new identity at AAPS – and today, has announced another acquisition as the company looks to represent “a new class of business,” says CEO.